Cat
Name
Size
Price
Action
MBS9018419-01
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8), partial (Active)
0.02 mg (Mammalian-Cell)
Ask
MBS9018419-02
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8), partial (Active)
0.1 mg (Mammalian-Cell)
Ask
MBS9018419-03
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8), partial (Active)
5x 0.1 mg (Mammalian Cell)
Ask
RPC28061-01
Recombinant Human Tumor necrosis factor ligand superfamily member 18 (TNFSF18) ,partial (Active)
20 µg
Ask
RPC28061-02
Recombinant Human Tumor necrosis factor ligand superfamily member 18 (TNFSF18) ,partial (Active)
100 µg
Ask
RPC28096-01
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9) ,partial (Active)
20 µg
Ask
RPC28096-02
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9) ,partial (Active)
100 µg
Ask
CSB-MP023996HU1c9-01
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) , partial (Active)
20 µg
Ask
CSB-MP023996HU1c9-02
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) , partial (Active)
100 µg
Ask
CSB-MP023996HU1c9-03
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) , partial (Active)
1 mg
Ask
CSB-MP023996HU1-01
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) , partial (Active)
20 µg
Ask
CSB-MP023996HU1-02
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) , partial (Active)
100 µg
Ask
CSB-MP023996HU1-03
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) , partial (Active)
1 mg
Ask
MBS7137714-01
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active)
0.02 mg
Ask
MBS7137714-02
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active)
0.1 mg
Ask
MBS7137714-03
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active)
1 mg
Ask
MBS7137714-04
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active)
5x 1 mg
Ask
RPC28080-01
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) ,partial (Active)
20 µg
Ask
RPC28080-02
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) ,partial (Active)
100 µg
Ask
CSB-AP002151HU-01
Recombinant Human Tumor necrosis factor protein (TNF) , partial (Active)
10 µg
Ask
CSB-AP002151HU-02
Recombinant Human Tumor necrosis factor protein (TNF) , partial (Active)
100 µg
Ask
CSB-AP002151HU-03
Recombinant Human Tumor necrosis factor protein (TNF) , partial (Active)
500 µg
Ask
CSB-AP002141HU-01
Recombinant Human Tumor necrosis factor protein (TNF) , partial (Active)
10 µg
Ask
CSB-AP002141HU-02
Recombinant Human Tumor necrosis factor protein (TNF) , partial (Active)
100 µg
Ask
CSB-AP002141HU-03
Recombinant Human Tumor necrosis factor protein (TNF) , partial (Active)
500 µg
Ask
CSB-AP005051RB-01
Recombinant Rabbit Tumor necrosis factor (TNF) , partial (Active)
50 µg
Ask
CSB-AP005051RB-02
Recombinant Rabbit Tumor necrosis factor (TNF) , partial (Active)
500 µg
Ask
CSB-AP005051RB-03
Recombinant Rabbit Tumor necrosis factor (TNF) , partial (Active)
1 mg
Ask
CSB-AP005031MO-01
Recombinant Mouse Tumor necrosis factor (TNF) , partial (Active)
50 µg
Ask
CSB-AP005031MO-02
Recombinant Mouse Tumor necrosis factor (TNF) , partial (Active)
500 µg
Ask
CSB-AP005031MO-03
Recombinant Mouse Tumor necrosis factor (TNF) , partial (Active)
1 mg
Ask
MBS9018420-01
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active)
0.02 mg (Mammalian-Cell)
Ask
MBS9018420-02
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active)
0.1 mg (Mammalian-Cell)
Ask
MBS9018420-03
Recombinant Human Tumor necrosis factor ligand superfamily member 9 (TNFSF9), partial (Active)
5x 0.1 mg (Mammalian Cell)
Ask
RPC28079-01
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) ,partial (Active)
20 µg
Ask
RPC28079-02
Recombinant Human Tumor necrosis factor ligand superfamily member 8 (TNFSF8) ,partial (Active)
100 µg
Ask
CSB-MP891791HU-01
Recombinant Human Tumor necrosis factor ligand superfamily member 18 (TNFSF18) , partial (Active)
20 µg
Ask
CSB-MP891791HU-02
Recombinant Human Tumor necrosis factor ligand superfamily member 18 (TNFSF18) , partial (Active)
100 µg
Ask
CSB-MP891791HU-03
Recombinant Human Tumor necrosis factor ligand superfamily member 18 (TNFSF18) , partial (Active)
1 mg
Ask
CSB-AP004851HU-01
Recombinant Human Tumor necrosis factor ligand superfamily member 11 (TNFSF11) , partial (Active)
50 µg
Ask
CSB-AP004851HU-02
Recombinant Human Tumor necrosis factor ligand superfamily member 11 (TNFSF11) , partial (Active)
500 µg
Ask
CSB-AP004851HU-03
Recombinant Human Tumor necrosis factor ligand superfamily member 11 (TNFSF11) , partial (Active)
1 mg
Ask
CSB-MP023991HUj2-01
Recombinant Human Tumor necrosis factor ligand superfamily member 14 (TNFSF14) , partial (Active)
20 µg
Ask
CSB-MP023991HUj2-02
Recombinant Human Tumor necrosis factor ligand superfamily member 14 (TNFSF14) , partial (Active)
100 µg
Ask
CSB-MP023991HUj2-03
Recombinant Human Tumor necrosis factor ligand superfamily member 14 (TNFSF14) , partial (Active)
1 mg
Ask
MBS6184978-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
0.1 mL
Ask
MBS6184978-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
5x 0.1 mL
Ask
MBS6184980-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
0.1 mL
Ask
MBS6184980-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
5x 0.1 mL
Ask
MBS6179204-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
0.1 mL
Ask
MBS6179204-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
5x 0.1 mL
Ask
MBS6176158-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
0.1 mL
Ask
MBS6176158-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
5x 0.1 mL
Ask
MBS6171748-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
0.1 mL
Ask
MBS6171748-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
5x 0.1 mL
Ask
MBS6171749-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
0.1 mL
Ask
MBS6171749-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
5x 0.1 mL
Ask
MBS6167340-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
0.1 mL
Ask
MBS6167340-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
5x 0.1 mL
Ask
CSB-AP002191HU-01
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) , partial (Active)
5 µg
Ask
CSB-AP002191HU-02
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) , partial (Active)
100 µg
Ask
CSB-AP002191HU-03
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) , partial (Active)
500 µg
Ask
RPC28039-01
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) ,partial (Active)
20 µg
Ask
RPC28039-02
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) ,partial (Active)
100 µg
Ask
MBS6174794-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
0.1 mL
Ask
MBS6174794-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
5x 0.1 mL
Ask
MBS6162928-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
0.1 mL
Ask
MBS6162928-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
5x 0.1 mL
Ask
MBS6167339-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
0.1 mL
Ask
MBS6167339-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
5x 0.1 mL
Ask
MBS6180569-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
0.1 mL
Ask
MBS6180569-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
5x 0.1 mL
Ask
MBS6180570-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
0.1 mL
Ask
MBS6180570-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
5x 0.1 mL
Ask
MBS6176160-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
0.1 mL
Ask
MBS6176160-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
5x 0.1 mL
Ask
MBS6171750-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
0.1 mL
Ask
MBS6171750-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
5x 0.1 mL
Ask
MBS6170384-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
0.1 mL
Ask
MBS6170384-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (Biotin)
5x 0.1 mL
Ask
MBS6162929-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
0.1 mL
Ask
MBS6162929-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
5x 0.1 mL
Ask
MBS6162930-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
0.1 mL
Ask
MBS6162930-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
5x 0.1 mL
Ask
MBS6167338-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
0.1 mL
Ask
MBS6167338-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
5x 0.1 mL
Ask
MBS6165974-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
0.1 mL
Ask
MBS6165974-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (APC)
5x 0.1 mL
Ask
MBS6161564-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
0.1 mL
Ask
MBS6161564-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (AP)
5x 0.1 mL
Ask
MBS6184979-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
0.1 mL
Ask
MBS6184979-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
5x 0.1 mL
Ask
MBS6183614-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
0.1 mL
Ask
MBS6183614-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (PE)
5x 0.1 mL
Ask
MBS6180568-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
0.1 mL
Ask
MBS6180568-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (HRP)
5x 0.1 mL
Ask
MBS6176159-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
0.1 mL
Ask
MBS6176159-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (FITC)
5x 0.1 mL
Ask
CSB-AP002341HU-01
Recombinant Human Tumor necrosis factor ligand superfamily member 15 protein (TNFSF15) , partial (Active)
5 µg
Ask
CSB-AP002341HU-02
Recombinant Human Tumor necrosis factor ligand superfamily member 15 protein (TNFSF15) , partial (Active)
100 µg
Ask
CSB-AP002341HU-03
Recombinant Human Tumor necrosis factor ligand superfamily member 15 protein (TNFSF15) , partial (Active)
500 µg
Ask
CSB-MP897523HU1-01
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) , partial (Active)
20 µg
Ask
CSB-MP897523HU1-02
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) , partial (Active)
100 µg
Ask
CSB-MP897523HU1-03
Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B) , partial (Active)
1 mg
Ask
CSB-AP002351HU-01
Recombinant Human Tumor necrosis factor ligand superfamily member 18 protein (TNFSF18) , partial (Active)
5 µg
Ask
CSB-AP002351HU-02
Recombinant Human Tumor necrosis factor ligand superfamily member 18 protein (TNFSF18) , partial (Active)
100 µg
Ask
CSB-AP002351HU-03
Recombinant Human Tumor necrosis factor ligand superfamily member 18 protein (TNFSF18) , partial (Active)
500 µg
Ask
CSB-AP001961HU-01
Recombinant Human Tumor necrosis factor ligand superfamily member 9 protein (TNFSF9) , partial (Active)
5 µg
Ask
CSB-AP001961HU-02
Recombinant Human Tumor necrosis factor ligand superfamily member 9 protein (TNFSF9) , partial (Active)
100 µg
Ask
CSB-AP001961HU-03
Recombinant Human Tumor necrosis factor ligand superfamily member 9 protein (TNFSF9) , partial (Active)
500 µg
Ask
MBS6227159-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
0.1 mL
Ask
MBS6227159-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
5x 0.1 mL
Ask
MBS6216484-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
0.1 mL
Ask
MBS6216484-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
5x 0.1 mL
Ask
MBS6216485-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
0.1 mL
Ask
MBS6216485-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
5x 0.1 mL
Ask
MBS6216487-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
0.1 mL
Ask
MBS6216487-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
5x 0.1 mL
Ask
MBS6205810-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
0.1 mL
Ask
MBS6205810-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
5x 0.1 mL
Ask
MBS6237835-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
0.1 mL
Ask
MBS6237835-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
5x 0.1 mL
Ask
MBS6195135-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
0.1 mL
Ask
MBS6195135-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
5x 0.1 mL
Ask
MBS6195136-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
0.1 mL
Ask
MBS6195136-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
5x 0.1 mL
Ask
MBS6195137-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
0.1 mL
Ask
MBS6195137-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
5x 0.1 mL
Ask
CSB-AP003471MO-01
Recombinant Mouse Tumor necrosis factor protein (TNF) , partial (Active)
5 µg
Ask
CSB-AP003471MO-02
Recombinant Mouse Tumor necrosis factor protein (TNF) , partial (Active)
100 µg
Ask
CSB-AP003471MO-03
Recombinant Mouse Tumor necrosis factor protein (TNF) , partial (Active)
500 µg
Ask
MBS6227161-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
0.1 mL
Ask
MBS6227161-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
5x 0.1 mL
Ask
MBS6227162-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
0.1 mL
Ask
MBS6227162-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
5x 0.1 mL
Ask
MBS6216486-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
0.1 mL
Ask
MBS6216486-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 550)
5x 0.1 mL
Ask
MBS6237834-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
0.1 mL
Ask
MBS6237834-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
5x 0.1 mL
Ask
MBS6237837-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
0.1 mL
Ask
MBS6237837-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
5x 0.1 mL
Ask
MBS6205809-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
0.1 mL
Ask
MBS6205809-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
5x 0.1 mL
Ask
MBS6205812-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
0.1 mL
Ask
MBS6205812-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
5x 0.1 mL
Ask
MBS6195134-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
0.1 mL
Ask
MBS6195134-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 405)
5x 0.1 mL
Ask
MBS6227160-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
0.1 mL
Ask
MBS6227160-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 650)
5x 0.1 mL
Ask
MBS6237836-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
0.1 mL
Ask
MBS6237836-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 750)
5x 0.1 mL
Ask
MBS6205811-01
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
0.1 mL
Ask
MBS6205811-02
CYLD (Cylindromatosis (Turban Tumor Syndrome), CDMT, CYLD1, CYLDI, EAC, FLJ20180, FLJ31664, FLJ78684, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2) (MaxLight 490)
5x 0.1 mL
Ask
CSB-MP729268MO-01
Recombinant Mouse Tumor necrosis factor ligand superfamily member 15 (TNFsf15) , partial (Active)
20 µg
Ask
CSB-MP729268MO-02
Recombinant Mouse Tumor necrosis factor ligand superfamily member 15 (TNFsf15) , partial (Active)
100 µg
Ask
CSB-MP729268MO-03
Recombinant Mouse Tumor necrosis factor ligand superfamily member 15 (TNFsf15) , partial (Active)
1 mg
Ask
CSB-MP004936HU1-01
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) , partial (Active)
20 µg
Ask
CSB-MP004936HU1-02
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) , partial (Active)
100 µg
Ask
CSB-MP004936HU1-03
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) , partial (Active)
1 mg
Ask
RPC28064-01
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) ,partial (Active)
20 µg
Ask
RPC28064-02
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) ,partial (Active)
100 µg
Ask
CSB-AP005181HU-01
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) , partial (Active)
50 µg
Ask
CSB-AP005181HU-02
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) , partial (Active)
500 µg
Ask
CSB-AP005181HU-03
Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40) , partial (Active)
1 mg
Ask
MBS3807118-01
Mouse Tumor Necrosis Factor-Like Weak Inducer Of Apoptosis ELISA Kit
48 Well
Ask
MBS3807118-02
Mouse Tumor Necrosis Factor-Like Weak Inducer Of Apoptosis ELISA Kit
96 Well
Ask
MBS3807118-03
Mouse Tumor Necrosis Factor-Like Weak Inducer Of Apoptosis ELISA Kit
5x 96 Well
Ask
MBS3807118-04
Mouse Tumor Necrosis Factor-Like Weak Inducer Of Apoptosis ELISA Kit
10x 96 Well
Ask
MBS7136879-01
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17), partial (Active)
0.02 mg (E-Coli)
Ask
MBS7136879-02
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17), partial (Active)
0.1 mg (E-Coli)
Ask
MBS7136879-03
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17), partial (Active)
0.02 mg (Yeast)
Ask
MBS7136879-04
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17), partial (Active)
0.1 mg (Yeast)
Ask
MBS7136879-05
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17), partial (Active)
0.02 mg (Baculovirus)
Ask
RPC28028-01
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) ,partial (Active)
20 µg
Ask
RPC28028-02
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) ,partial (Active)
100 µg
Ask
RPC28097-01
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) ,partial (Active)
20 µg
Ask
RPC28097-02
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) ,partial (Active)
100 µg
Ask
CSB-MP896537HU-01
Recombinant Human Tumor necrosis factor receptor superfamily member 18 (TNFRSF18) , partial (Active)
20 µg
Ask
CSB-MP896537HU-02
Recombinant Human Tumor necrosis factor receptor superfamily member 18 (TNFRSF18) , partial (Active)
100 µg
Ask
CSB-MP896537HU-03
Recombinant Human Tumor necrosis factor receptor superfamily member 18 (TNFRSF18) , partial (Active)
1 mg
Ask
CSB-MP842173HU-01
Recombinant Human Tumor necrosis factor receptor superfamily member 14 (TNFRSF14) , partial (Active)
20 µg
Ask
CSB-MP842173HU-02
Recombinant Human Tumor necrosis factor receptor superfamily member 14 (TNFRSF14) , partial (Active)
100 µg
Ask
CSB-MP842173HU-03
Recombinant Human Tumor necrosis factor receptor superfamily member 14 (TNFRSF14) , partial (Active)
1 mg
Ask
CSB-MP023978HU2-01
Recombinant Human Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) , partial (Active)
20 µg
Ask
CSB-MP023978HU2-02
Recombinant Human Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) , partial (Active)
100 µg
Ask
CSB-MP023978HU2-03
Recombinant Human Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) , partial (Active)
1 mg
Ask
CSB-AP005151HU-01
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) , partial (Active)
50 µg
Ask
CSB-AP005151HU-02
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) , partial (Active)
500 µg
Ask
CSB-AP005151HU-03
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) , partial (Active)
1 mg
Ask
CSB-AP005141HU-01
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) , partial (Active)
50 µg
Ask
CSB-AP005141HU-02
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) , partial (Active)
500 µg
Ask
CSB-AP005141HU-03
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9) , partial (Active)
1 mg
Ask
MBS7135718-01
Recombinant Human Tumor Necrosis Factor Receptor Superfamily Member 17 (TNFRSF17), Partial (Active)
0.02 mg
Ask
MBS7135718-02
Recombinant Human Tumor Necrosis Factor Receptor Superfamily Member 17 (TNFRSF17), Partial (Active)
0.1 mg
Ask
MBS7135718-03
Recombinant Human Tumor Necrosis Factor Receptor Superfamily Member 17 (TNFRSF17), Partial (Active)
1 mg
Ask
MBS7135718-04
Recombinant Human Tumor Necrosis Factor Receptor Superfamily Member 17 (TNFRSF17), Partial (Active)
5x 1 mg
Ask
MBS9018417-01
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9), partial (Active)
0.02 mg
Ask
MBS9018417-02
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9), partial (Active)
0.1 mg
Ask
MBS9018417-03
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9), partial (Active)
1 mg
Ask
MBS9018417-04
Recombinant Human Tumor necrosis factor receptor superfamily member 9 (TNFRSF9), partial (Active)
5x 1 mg
Ask
MBS9018416-01
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8), partial (Active)
0.02 mg (Mammalian-Cell)
Ask
MBS9018416-02
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8), partial (Active)
0.1 mg (Mammalian-Cell)
Ask
MBS9018416-03
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8), partial (Active)
5x 0.1 mg (Mammalian Cell)
Ask
RPC28060-01
Recombinant Human Tumor necrosis factor receptor superfamily member 18 (TNFRSF18) ,partial (Active)
20 µg
Ask
RPC28060-02
Recombinant Human Tumor necrosis factor receptor superfamily member 18 (TNFRSF18) ,partial (Active)
100 µg
Ask
RPC28045-01
Recombinant Human Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) ,partial (Active)
20 µg
Ask
RPC28045-02
Recombinant Human Tumor necrosis factor receptor superfamily member 1B (TNFRSF1B) ,partial (Active)
100 µg
Ask
CSB-AP004921HU
Recombinant Human Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B), partial (Active)
1 mg
Ask
CSB-MP023983HU1-01
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8) , partial (Active)
20 µg
Ask
CSB-MP023983HU1-02
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8) , partial (Active)
100 µg
Ask
CSB-MP023983HU1-03
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8) , partial (Active)
1 mg
Ask
CSB-MP023974HU1-01
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) , partial (Active)
20 µg
Ask
CSB-MP023974HU1-02
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) , partial (Active)
100 µg
Ask
CSB-MP023974HU1-03
Recombinant Human Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) , partial (Active)
1 mg
Ask
CSB-AP005241HU-01
Recombinant Human Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) , partial (Active)
50 µg
Ask
CSB-AP005241HU-02
Recombinant Human Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) , partial (Active)
500 µg
Ask
CSB-AP005241HU-03
Recombinant Human Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) , partial (Active)
1 mg
Ask
CSB-AP001951HU-01
Recombinant Human Tumor necrosis factor receptor superfamily member 9 protein (TNFRSF9) , partial (Active)
5 µg
Ask
CSB-AP001951HU-02
Recombinant Human Tumor necrosis factor receptor superfamily member 9 protein (TNFRSF9) , partial (Active)
100 µg
Ask
CSB-AP001951HU-03
Recombinant Human Tumor necrosis factor receptor superfamily member 9 protein (TNFRSF9) , partial (Active)
500 µg
Ask
RPC28078-01
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8) ,partial (Active)
20 µg
Ask
RPC28078-02
Recombinant Human Tumor necrosis factor receptor superfamily member 8 (TNFRSF8) ,partial (Active)
100 µg
Ask
RPC28047-01
Recombinant Human Tumor necrosis factor receptor superfamily member 14 (TNFRSF14) ,partial (Active)
20 µg
Ask
RPC28047-02
Recombinant Human Tumor necrosis factor receptor superfamily member 14 (TNFRSF14) ,partial (Active)
100 µg
Ask
RPC28066-01
Recombinant Human Tumor necrosis factor receptor superfamily member 13C (TNFRSF13C) ,partial (Active)
20 µg
Ask
RPC28066-02
Recombinant Human Tumor necrosis factor receptor superfamily member 13C (TNFRSF13C) ,partial (Active)
100 µg
Ask
CSB-AP003221MOW-01
Recombinant Rhesus Macaque Tumor necrosis factor protein (TNF) , partial (Active)
5 µg
Ask
CSB-AP003221MOW-02
Recombinant Rhesus Macaque Tumor necrosis factor protein (TNF) , partial (Active)
100 µg
Ask
CSB-AP003221MOW-03
Recombinant Rhesus Macaque Tumor necrosis factor protein (TNF) , partial (Active)
500 µg
Ask
CSB-MP023072HU2-01
Recombinant Human Tumor-associated calcium signal transducer 2 (TACSTD2) , partial (Active)
100 µg
Ask
CSB-MP023072HU2-02
Recombinant Human Tumor-associated calcium signal transducer 2 (TACSTD2) , partial (Active)
20 µg
Ask
CSB-MP023072HU2-03
Recombinant Human Tumor-associated calcium signal transducer 2 (TACSTD2) , partial (Active)
1 mg
Ask
MBS7135715-01
Recombinant Human Tumor-Associated Calcium Signal Transducer 2 (TACSTD2), Partial (Active)
0.02 mg
Ask
MBS7135715-02
Recombinant Human Tumor-Associated Calcium Signal Transducer 2 (TACSTD2), Partial (Active)
0.1 mg
Ask
MBS7135715-03
Recombinant Human Tumor-Associated Calcium Signal Transducer 2 (TACSTD2), Partial (Active)
1 mg
Ask
MBS7135715-04
Recombinant Human Tumor-Associated Calcium Signal Transducer 2 (TACSTD2), Partial (Active)
5x 1 mg
Ask
MBS6370332-01
ARL11 (ADP-ribosylation Factor-like Protein 11, ADP-ribosylation Factor-like Tumor Suppressor Protein 1, ARLTS1, FLJ33930, MGC17429) APC
0.1 mL
Ask
MBS6370332-02
ARL11 (ADP-ribosylation Factor-like Protein 11, ADP-ribosylation Factor-like Tumor Suppressor Protein 1, ARLTS1, FLJ33930, MGC17429) APC
5x 0.1 mL
Ask
TS900-25
Core Panel Multi-Tumor control slides
Set of 25
Ask
TS900
Core Panel Multi-Tumor control slides
Set of 5
Ask
MBS6370335-01
ARL11 (ADP-ribosylation Factor-like Protein 11, ADP-ribosylation Factor-like Tumor Suppressor Protein 1, ARLTS1, FLJ33930, MGC17429) (HRP)
0.1 mL
Ask
MBS6370335-02
ARL11 (ADP-ribosylation Factor-like Protein 11, ADP-ribosylation Factor-like Tumor Suppressor Protein 1, ARLTS1, FLJ33930, MGC17429) (HRP)
5x 0.1 mL
Ask